The blood testing market in Germany is expected to reach a projected revenue of US$ 5,982.9 million by 2030. A compound annual growth rate of 7.1% is expected of Germany blood testing market from 2025 to 2030.
The Germany blood testing market generated a revenue of USD 3,995.7 million in 2024 and is expected to reach USD 5,982.9 million by 2030.
The Germany market is expected to grow at a CAGR of 7.1% from 2025 to 2030.
In terms of segment, covid-19 testing was the largest revenue generating test type in 2024.
Glucose testing is the most lucrative test type segment registering the fastest growth during the forecast period.
Blood testing market data book summary
Market revenue in 2024
USD 3,995.7 million
Market revenue in 2030
USD 5,982.9 million
Growth rate
7.1% (CAGR from 2025 to 2030)
Largest segment
Covid-19 testing
Fastest growing segment
Glucose testing
Historical data
2018 - 2023
Base year
2024
Forecast period
2025 - 2030
Quantitative units
Revenue in USD million
Market segmentation
Glucose testing, A1C testing, Direct LDL testing, Lipid panel testing, Prostate-specific antigen testing, COVID-19 testing, BUN testing, Vitamin D testing, Thyroid-stimulating hormone testing, Serum Nicotine / Cotinine testing, High sensitivity CRP testing, Testosterone testing, ALT testing, Cortisol testing, Creatinine testing, AST testing, Other blood tests
Key market players worldwide
Abbott Laboratories, Roche Holding AG ADR, Bio-Rad Laboratories Inc, BioMerieux SA, Quest Diagnostics Inc, Biomerica Inc, Becton Dickinson & Co, Siemens Healthineers AG ADR, Danaher Corp, Trinity Biotech PLC ADR
Other key industry trends
In terms of revenue, Germany accounted for 4.1% of the global blood testing market in 2024.
Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
In Europe, Germany blood testing market is projected to lead the regional market in terms of revenue in 2030.
Russia is the fastest growing regional market in Europe and is projected to reach USD 2,254.6 million by 2030.
Germany is the largest contributor to Europe blood testing market. In 2020, Germany accounted for the highest market share owing to high healthcare expenditure, easy availability of products, and presence of well-equipped laboratories.
New market entrants are strategically collaborating with various companies to enhance rapid diagnostic technology, which is anticipated to boost the market growth in Germany during the forecast period.
For instance, in August 2019, Expedeon AG signed a commercial agreement with Sona Nanotech, Inc. As per the agreement, Expedeon will be providing its bioconjugation technologies, gold nanoparticle, and expertise, while Sona Nanotech, Inc. will be offering its lateral flow developing services.
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Blood Testing Market Outlook will help companies and investors design strategic landscapes.
Covid-19 Testing was the largest segment with a revenue share of 16.11% in 2024.
Horizon Databook has segmented the Germany blood testing market based on glucose testing, a1c testing, direct ldl testing, lipid panel testing, prostate-specific antigen testing, covid-19 testing, bun testing, vitamin d testing, thyroid-stimulating hormone testing, serum nicotine / cotinine testing, high sensitivity crp testing, testosterone testing, alt testing, cortisol testing, creatinine testing, ast testing, other blood tests covering the revenue growth of each sub-segment from 2018 to 2030.
Germany is the largest contributor to Europe blood testing market. In 2020, Germany accounted for the highest market share owing to high healthcare expenditure, easy availability of products, and presence of well-equipped laboratories.
New market entrants are strategically collaborating with various companies to enhance rapid diagnostic technology, which is anticipated to boost the market growth in Germany during the forecast period.
For instance, in August 2019, Expedeon AG signed a commercial agreement with Sona Nanotech, Inc. As per the agreement, Expedeon will be providing its bioconjugation technologies, gold nanoparticle, and expertise, while Sona Nanotech, Inc. will be offering its lateral flow developing services.
Germany Blood Testing Market Test Type Outlook (Revenue, USD Million , 2018-2030)
Glucose testing
A1C testing
Direct LDL testing
Lipid panel testing
Prostate-specific antigen testing
COVID-19 testing
BUN testing
Vitamin D testing
Thyroid-stimulating hormone testing
Serum Nicotine / Cotinine testing
High sensitivity CRP testing
Testosterone testing
ALT testing
Cortisol testing
Creatinine testing
AST testing
Other blood tests
Reasons to subscribe to Blood Testing Market Outlook databook
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Blood Testing Market Outlook databook
Our clientele includes a mix of Blood Testing Market Outlook companies, investment firms, advisory firms & academic institutions.
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Germany Blood Testing Market Outlook, including forecasts for subscribers. This country databook contains high-level insights into Germany Blood Testing Market Outlook from 2018 to 2030, including revenue numbers, major trends, and company profiles.